3 Result: Inogen
FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis
October 30th, 2026
Groundbreaking therapy provides additional treatment option that fights the disease at its source, not only its symptoms Silver Spring, MD / CRWE PRESS RELEASE / October 30, 2026 - The U.S. Food and Drug Administration today granted accelera. Read more
Inogen's Q2 Revenue Outlook Falls Short; UBS' Bullish Stance on Microsoft
July 14th, 2023
Inogen, Inc. (Nasdaq: INGN) issued a preliminary, unaudited financial update for the second quarter of 2023, revealing lower-than-expected revenue figures. The company estimates that total revenue for the quarter will fall within the range of $83 . Read more
Lucintel Forecasts Polylactic Acid Market to Reach $5.4 Million by 2025
April 10th, 2022
Dallas, TX / CRWE PRESS RELEASE / April 11, 2022 - According to the recent study the polylactic acid market is projected to reach an estimated $5.4 Million by 2025 from $1.7 Million in 2019, at a CAGR of 21.6% from 2020 to 2025. Growth in this m. Read more
Want To Find Some News?
News By Industries
Recent Post
-
Treasury Targets Global Scam Networks and the Corporate Infrastructure That Enables Them
November 06th, 2026FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma
November 05th, 2026New Details Emerge in Amazon Ads Auction-Rigging Case
November 05th, 2026November 02nd, 2026
Member Login